NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
RECENT NEWS
#TBT: Gaps in Quality Measurement & ACOs’ Effectiveness
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
E.V.I.dently February 2015
NPC MessageBiopharmaceutical Innovation and the Changing Health Care SystemDuring the last decade, we have seen... moreCER Tweets of the Week: #HealthDataChat, UNC Calls for Abstracts for Its CER Symposium (February 16-20)
This week, comparative effectiveness research (CER) stakeholders engaged in a #healthdatachat with AcademyHealth... moreMinding the Gaps in Quality Measurement: A Conversation With Discern Health’s Dr. Tom Valuck
The U.S. Department of Health and Human Services (HHS) announced in January that its target is to have “30% of... more
Biopharmaceutical Innovation and the Changing Health Care System
During the last decade, we have seen significant progress in biopharmaceutical innovation. Today, there are... morePCORI Approves Pragmatic Studies Funding; Adopts Policy for Peer Review and Release of Research Findings
This month, the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors:Approved $64.1 million... moreCER Certificate Program Makes It Easier to Evaluate Studies Used in Health Care Decisions
Now more than ever, there is an abundance of comparative effectiveness research (CER) for health care decision-... morePCORI Approves Obesity-Targeted Funding Announcement; Continues To Seek Applications For Stakeholder Advisory Panels
This month, the Patient-Centered Outcomes Research Institute (PCORI):Approved the development of an obesity-... more
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council
Washington, D.C. (December 9, 2014)—The National Pharmaceutical Council (NPC) today welcomed two leading... moreImproving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
Washington, D.C. (December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed... moreEisai’s David Martin Elected as National Pharmaceutical Council’s Chairman of the Board
Washington, D.C. (November 7, 2014)—The National Pharmaceutical Council (NPC) today announced that David J.... moreNational Pharmaceutical Council, Discern Health Examine Accountable Care Measures for Specialty Care and Innovative Treatment
Washington, DC (October 28, 2014)— Measuring the quality and cost of health care is an integral part of... more
Chain Drug Review – Commentary: “Health Care Outlook for 2015”
This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard,... moreNPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings
November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite... moreHealthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data
March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... moreNPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
Why are quality measures important? We asked health care thought leaders to tell us why.
Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using... moreAccess to Specialty Medications & Value-Based Insurance Design
Specialty medications have been making health care headlines because of their effectiveness and higher costs.... moreConsumer-Directed Health Plans
A unique survey of large employers sheds light on the strategies and best practices that they follow when... moreHealth Technology Assessments and Specialty Medications
David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... more#TBT: Gaps in Quality Measurement & ACOs’ Effectiveness
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreMinding the Gaps in Quality Measurement: A Conversation With Discern Health’s Dr. Tom Valuck
The U.S. Department of Health and Human Services (HHS) announced in January that its target is to have “30% of... moreCER Tweets of the Week: #HealthDataChat, UNC Calls for Abstracts for Its CER Symposium (February 16-20)
This week, comparative effectiveness research (CER) stakeholders engaged in a #healthdatachat with AcademyHealth... more